Results 41 to 50 of about 58,634 (303)

Use of Right Ventricular Assist Device Post-Left Ventricular Assist Device Placement

Hearts
Right heart failure (RHF) is a common manifestation after left ventricular assist device (LVAD) placement and is associated with a high mortality rate. Historically, RV failure requiring an RVAD at the time of LVAD implantation has been associated with ...
Shannon Parness, Tori E. Hester, Harish Pandyaram, Panagiotis Tasoudis, Aurelie E. Merlo   +4 more
doaj   +1 more source

Cardiovascular prevention and rehabilitation for patients with ventricular assist device From exercise therapy to long-term therapy Part I: exercise therapy

Monaldi Archives for Chest Disease, 2015
In the present context of an aging population, limited donor heart availability, improved reliability of mechanical cardiac support and improved patient outcomes, ventricular assist device (VAD) options to support end-stage heart failure patients are ...
Ugo Corrà, Massimo Pistono, Alessandro Mezzani, Marco Gnemmi, Franco Tarro Genta, Roberto Caruso, Pantaleo Giannuzzi   +6 more
doaj   +1 more source

Intravenous administration of umbilical cord lining stem cells in left ventricular assist device recpieint: Rational and design of the uSTOP LVAD BLEED pilot study

American Heart Journal Plus, 2022
Background: Left ventricular assist device (LVAD) implantation provides a robust survival advantage, however despite improvements in mortality, the adverse event burden of durable mechanical circulatory support remains high.
Mustafa M. Ahmed, Lauren E. Meece, Eileen M. Handberg, Carl J. Pepine   +3 more
doaj   +1 more source

Ex-vivo recruitment and x-ray assessment of donor lungs in a challenging retrieval from a donor supported by lvad using the portable normothermic perfusion system: A case report [PDF]

, 2017
Lung transplantation (LTx) is limited by the shortage of suitable donors. To overcome this problem, many programs have begun to use donors with extended criteria (marginal donors).
Calabrese, Fiorella, Calabrese, Francesca, DI GREGORIO, Guido, Loy, Monica, Marulli, Giuseppe, Rea, Federico, Rebusso, Alessandro, Schiavon, Marco   +7 more
core   +1 more source

Left ventricular assist device.

New England Journal of Medicine, 2002
To the Editor: The value of angiotensin-converting– enzyme (ACE) inhibitors, beta-blockers, and spironolactone has been well established by the results of numerous clinical trials. About 70 percent of the patients described by Rose et al. were treated with ACE inhibitors or angiotensin II–receptor antagonists; 35 to 40 percent received spironolactone ...
Jiménez-Navarro, Manuel, Molero, Encarnación, Teresa, Eduardo de   +2 more
openaire   +3 more sources

Lessons Learned From a Delayed‐Start Trial of Modafinil for Freezing of Gait in Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Freezing of gait (FOG) in people with Parkinson's disease (PwPD) is debilitating and has limited treatments. Modafinil modulates beta/gamma band activity in the pedunculopontine nucleus (PPN), like PPN deep brain stimulation. We therefore tested the hypothesis that Modafinil would improve FOG in PwPD.
Tuhin Virmani, Lakshmi Pillai, Reid D. Landes, Aliyah Glover, Shannon Doerhoff, Jennifer Kleiner, Mitesh Lotia, Rohit Dhall, Edgar Garcia‐Rill   +8 more
wiley   +1 more source

Stent implantation in a left ventricular assist device

REC: Interventional Cardiology (English Ed.), 2020
Sixty-eight-year-old male patient carrier of one HeartWare left ventricular assist device as destination therapy due to ischemic dilated cardiomyopathy.
Raquel Álvarez Ramos, Luis María Andrés Lalaguna, José Luis Díez Gil   +2 more
doaj   +1 more source

Value of MRI Outcomes for Preventive and Early‐Stage Trials in Spinocerebellar Ataxias 1 and 3

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To examine the value of MRI outcomes as endpoints for preventive and early‐stage trials of two polyglutamine spinocerebellar ataxias (SCAs). Methods A cohort of 100 participants (23 SCA1, 63 SCA3, median Scale for the Assessment and Rating of Ataxia (SARA) score = 5, 42% preataxic, and 14 gene‐negative controls) was scanned at 3T up ...
Thiago J. R. Rezende, Emilien Petit, Young Woo Park, Sophie Tezenas du Montcel, James M. Joers, Jonathan M. DuBois, H. Moore Arnold, Michal Povazan, Ipek Özdemir, Guita Banan, Romain Valabregue, Philipp Ehses, Jennifer Faber, Chiadi U. Onyike, Peter B. Barker, Jeremy D. Schmahmann, Eva‐Maria Ratai, Sub H. Subramony, Thomas H. Mareci, Khalaf O. Bushara, Henry Paulson, Thomas Klockgether, Alexandra Durr, Tetsuo Ashizawa, Christophe Lenglet, Gülin Öz, READISCA Investigators   +26 more
wiley   +1 more source

Impact of preoperative versus postoperative dialysis on left ventricular assist device outcomes: An analysis from the Society of Thoracic Surgeons Interagency Registry for Mechanically Assisted Circulatory Support databaseCentral MessagePerspective

JTCVS Open, 2022
Objective: Chronic kidney disease and renal failure are common in patients being considered for left ventricular assist device support. We sought to evaluate the outcomes of patients undergoing left ventricular assist device implantation with ...
J. Hunter Mehaffey, MD, MSc, Ryan Cantor, PhD, Susan Myers, MS, Nicholas R. Teman, MD, John A. Kern, MD, Gorav Ailawadi, MD, Francis Pagani, MD, James Kirklin, MD, Kenan Yount, MD, MBA, Leora Yarboro, MD   +9 more
doaj   +1 more source

Giant cell myocarditis masquerading as orbital myositis with a rapid, fulminant course necessitating mechanical support and heart transplantation. [PDF]

, 2017
Giant cell myocarditis (GCM), a rapidly progressive inflammation of the myocardium, is associated with fulminant heart failure, refractory ventricular arrhythmias, and conduction system abnormalities.
Aksoy, Olcay, Ardehali, Reza, Garg, Vinisha, Huynh, Tracy, Shah, Janki, Tan, Weiyi   +5 more
core   +1 more source